Biotech
BioLineRx Class Action Alert: Submit Your Losses to Johnson Fistel
The Class Action Seeks to Recover Damages on Shareholders’ Behalf SAN DIEGO, Jan. 05, 2023 (GLOBE NEWSWIRE) — Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf more...
Energy
Canadian Solar (CSIQ) to Supply 550MWh Energy Storage Products
Canadian Solar Inc. CSIQ recently revealed that CSI Energy Storage, part of the company’s CSI Solar subsidiary, has signed a supply agreement with United Kingdom’s (U.K.) Pulse Clean Energy. Per the terms of the agreement, more...
Biotech
Cyclacel Pharmaceuticals Reviews 2022 Achievements and Announces Key Business Objectives for 2023
– Determination of Recommended Phase 2 Dose and Start of Phase 2 in 1Q 2023 for Oral Fadraciclib – – 2/3 Partial Responses in Lymphoma and 11/15 Stable Disease in Advanced Solid Tumors – – Expecting more...
Biotech
CNS Pharmaceuticals to Present at the Virtual Investor 2023 Companies to Watch Event
CNS Pharmaceuticals to Present at the Virtual Investor 2023 Companies to Watch Event PR Newswire Live video webcast on Wednesday, January 18 th at 10:00 AM ET HOUSTON , January 5, 2023 /PRNewswire/ — CNS more...
Biotech
Acasti to Host Conference Call on Tuesday, January 10, 2023 to Discuss Results from Recent Phase 1 PK Studies for GTX-101 and GTX-102 That Met All Outcome Measures
LAVAL, Québec, Jan. 05, 2023 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical stage drug candidates addressing rare and orphan more...
Health
“Modern Miracles”: ReWalk Technology Showcased at the Hanukkah Celebration Hosted by the Embassy of the State of Israel to Belgium and Luxembourg in Antwerp
ReWalk Robotics, Ltd. is honored to have presented its technology at the prestigious Modern Miracles Celebration with the Embassy of the State of Israel to Belgium and Luxembourg in Antwerp. MARLBOROUGH, Mass., BERLIN, and YOKNEAM, more...
Biotech
Acer Therapeutics Announces Initiation of Two Investigator-Sponsored Trials of ACER-801 (Osanetant) in Men with Adenocarcinoma of the Prostate
POSH-MAP and PORT-MAP investigator-sponsored trials to evaluate ability of ACER-801 (osanetant) to reduce hot flashes and as neoadjuvant therapy in men with prostate cancer NEWTON, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. more...
Biotech
MONDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California–(Newsfile Corp. – January 5, 2023) – The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Eiger BioPharmaceuticals, Inc. (“Eiger” or “the Company”) more...
Health
Bionano Genomics Reports Preliminary Fourth Quarter and Full-Year 2022 Results
– Preliminary Q4 revenue expected to be between $8.1 and $8.4 million; 29% to 33% increase over Q4 2021 – Reached installed base of 240 systems as of YE 2022; 46% increase over YE 2021 more...
Health
EDAP Announces Record Q4 US Focal One Placements
Company preliminarily reports nine Focal One Placements in the U.S. , including seven sales LYON, France, January 5, 2023 — EDAP TMS SA (NASDAQ: EDAP) (the “Company”), the global leader in robotic energy-based therapies, announced more...